Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
RedHill Biopharma Ltd [US7574681034/RDHL]   
[15/12/2021]

RedHill Biopharma Ltd : RedHill Announces Additional Insider Buying

RALEIGH, NC and TELAVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. NASDAQ:RDHL "RedHill" or the "Company", a specialty biopharmaceutical company, today announced that members of its board of directors and senior management, including the Companys Chairman & CEO, Mr. Dror BenAsher, collectively purchased approximately an additional 66,0... Lire le communiqué
 
RedHill Biopharma Ltd [US7574681034/RDHL]   
[09/12/2021]

RedHill Biopharma Ltd : RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences PublicationDespite increasing resistance to, and suboptimal H. pylori eradication rates with, clarithromycin, a new study, published in Digestive Diseases and Sciences, indicates that over 80% of all prescriptions for H.... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de RedHill...